Previous studies indicate that miR-150 mitigates adverse remodeling and fibrosis following myocardial infarction by targeting pro-fibrotic genes such as Hoxa4 and apoptosis-related genes like Gdap1l1, thereby improving cardiac function [43]. This evidence concerns the gene GDAP1L1 and myocardial infarction.